An expert review on the use of tenofovir alafenamide for the treatment of chronic hepatitis B virus infection in Asia

Asia has intermediate-to-high prevalence and high morbidity of hepatitis B virus (HBV) infection. The use of guideline-recommended nucleos(t)ide analogs with high barrier to resistance, such as entecavir (ETV), tenofovir disoproxil fumarate (TDF), and tenofovir alafenamide (TAF), is one of the key i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Gastroenterol
Main Authors: Charlton, Michael R., Alam, Altaf, Shukla, Akash, Dashtseren, Bekhbold, Lesmana, Cosmas Rinaldi Adithya, Duger, Davadoorj, Payawal, Diana Alcantara, Duy Cuong, Do, Jargalsaikhan, Ganbolor, Cua, Ian Homer Yee, Sollano, Jose Decena, Singh, Karam Romeo, Madan, Kaushal, Win, Khin Maung, Kyi, Khin Pyone, Tun, Kyaw Soe, Salih, Mohd., Rastogi, Mukul, Saraf, Neeraj, Thuy, Pham Thi Thu, Hien, Pham Tran Dieu, Gani, Rino Alvani, Mohamed, Rosmawati, Tanwandee, Tawesak, Piratvisuth, Teerha, Sukeepaisarnjaroen, Wattana, Naing, Win, Hashmi, Zahid Yasin
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Singapore 2020
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7452871/
https://ncbi.nlm.nih.gov/pubmed/32666200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00535-020-01698-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados